FreeTCCL Archive New Biomarker Findings Show Improvement in KRAS Subtype in Phase III Erbitux Trial May 29, 2014Vol.37 No.05
FreeTCCL Archive Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse May 29, 2014Vol.37 No.05
FreeTCCL Archive ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer May 29, 2014Vol.37 No.05
FreeTCCL Archive Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening May 29, 2014Vol.37 No.05
FreeTCCL Archive ASCO Releases Three Guidelines For Cancer Survivorship Care May 01, 2014Vol.37 No.04
FreeTCCL Archive LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I May 01, 2014Vol.37 No.04
FreeTCCL Archive Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen May 01, 2014Vol.37 No.04
FreeTCCL Archive Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate May 01, 2014Vol.37 No.04
